Selective 5‐HT2 receptor blockade in exercise‐induced asthma
- 1 July 1985
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 15 (4) , 371-376
- https://doi.org/10.1111/j.1365-2222.1985.tb03005.x
Abstract
Seven young extrinsic asthmatics participated in an open, pilot study to determine the protective effect of a selective 5‐hydroxytryptamine (5‐HT) blocking agent, ketanserin, on exercise induced asthma. ketanserin in a dose of 10 mg given intravenously 20 min before exercise altered the basal bronchomotor tone in only 1 of 6 subjects and offered partial protection against exercise‐induced bronchoconstriction in 1 of 5 asthmatics with no overall effect in the group. All patients experienced sleepiness after administration of ketanserin and one had bradycardia with hypotension. The ineffectiveness of ketanserin suggests indirectly that serotonin has a limited role in the pathogenesis of exercise‐induced asthma.Keywords
This publication has 7 references indexed in Scilit:
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Platelet Activation during Antigen-Induced Airway Reactions in Asthmatic SubjectsNew England Journal of Medicine, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Interaction between serotonin and efferent vagus nerves in dog lungsJournal of Applied Physiology, 1978
- Intravascular Aggregation and Pulmonary Sequestration of Platelets during IgE-Induced Systemic Anaphylaxis in the Rabbit: Abrogation of Lethal Anaphylactic Shock by Platelet DepletionThe Journal of Immunology, 1977
- Studies in allergyJournal of Allergy, 1960
- Serotonin and Histamine in Mast CellsScience, 1957